European Medicines Agency: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett No edit summary |
mNo edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 8: | Line 8: | ||
==References== | ==References== | ||
{{reflist}}[[Category:Suggestion Bot Tag]] | |||
Latest revision as of 06:01, 14 August 2024
The European Medicines Agency (EMEA) is an agency of the European Union. It was known as the "European Agency for the Evaluation of Medicinal Products" until 2004.[1]
Most of its funding is from fees collected from entities submitted applications.[2]
Purpose
"European Medicines Agency (EMEA) is a decentralised body of the European Union with headquarters in London. Its main responsibility is the protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use."[3]
References
- ↑ Anonymous. (March, 2004) Regulation (EC) no 726/2004 of the European Parliament and of the Council. Official Journal of the European Union
- ↑ Kao DP (2008). "What can we learn from drug marketing efficiency?". BMJ 337: a2591. PMID 19050331. [e]
- ↑ Anonymous. About EMEA - Overview. European Medicines Agency.